Dr Alfredo Caturano
Role: Clinical Researcher / Assistant Professor of Internal Medicine
Institute: San Raffaele Roma Open University, Department of Human Sciences and Promotion of the Quality of Life, Rome, Italy
Research & Interests: Dr Alfredo Caturano is a clinical researcher with a particular interest in diabetes and related complications, especially in the areas of cardiovascular disease and metabolic dysfunction-associated steatotic liver disease (MASLD). In 2016, he graduated from the Università degli Studi della Campania “Luigi Vanvitelli,” Naples, Italy, where he later specialized in Internal Medicine in 2021. His specialization thesis, which explored the impact of glycemic control on cardiovascular outcomes in type 2 diabetes with and without multifactorial treatment, earned recognition from the Italian Society of Diabetology, receiving an award for its excellence.
In 2023, Dr Caturano was selected for the European Association for the Study of Diabetes (EASD) Early Career Academy Mentorship Programme. Under the guidance of Prof. Jan Gojda at Charles University, Prague, he received advanced training in metabolic research techniques, including the hyperinsulinemic-euglycemic clamp.
Dr Caturano earned his PhD in Clinical and Experimental Sciences in January 2025 at the Università degli Studi della Campania “Luigi Vanvitelli.” His thesis highlighted the positive impact of empagliflozin and metformin combination therapy versus metformin monotherapy on MASLD progression in patients with type 2 diabetes.
Currently, Dr Caturano serves as an Assistant Professor of Internal Medicine at San Raffaele Roma Open University, Rome, Italy. He also holds a leadership role as Regional Counselor for the Campania-Basilicata region within the Italian Society of Diabetology, where he actively fosters research and advancements in diabetes care.
Dr Caturano has presented his research at national and international conferences. His long-term goal is to advance personalized medicine approaches to improve outcomes in patients living with diabetes.